Virology

Journal

• Overview
• Identity
• View All

Overview

articles

• Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category.  519:99-105. 2018
• Structure-based assessment of protein-protein interactions and accessibility of protein IX in adenoviruses with implications for antigen display.  516:102-107. 2018
• Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture.  517:148-156. 2017
• Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.  501:35-46. 2017
• Dynamic conformational changes in the rhesus TRIM5α dimer dictate the potency of HIV-1 restriction.  500:161-168. 2017
• Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction.  505:193-209. 2017
• Identification and characterization of a naturally occurring, efficiently cleaved, membrane-bound, clade A HIV-1 Env, suitable for immunogen design, with properties comparable to membrane-bound BG505.  510:22-28. 2017
• Immunological and pathological consequences of coxsackievirus RNA persistence in the heart.  512:104-112. 2017
• Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein.  512:161-171. 2017
• Resistance of human plasmacytoid dendritic CAL-1 cells to infection with lymphocytic choriomeningitis virus (LCMV) is caused by restricted virus cell entry, which is overcome by contact of CAL-1 cells with LCMV-infected cells.  511:106-113. 2017
• Binding and entry of a non-enveloped T=4 insect RNA virus is triggered by alkaline pH.  498:277-287. 2016
• Capture and characterization of influenza A virus from primary samples using glycan bead arrays.  493:128-135. 2016
• TCR independent suppression of CD8(+) T cell cytokine production mediated by IFNγ in vivo.  498:69-81. 2016
• Adenovirus membrane penetration: Tickling the tail of a sleeping dragon.  479:591-599. 2015
• Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes.  475:37-45. 2015
• Regulation of human genome expression and RNA splicing by human papillomavirus 16 E2 protein.  468:10-18. 2014
• The delta domain of the HK97 major capsid protein is essential for assembly.  456:171-178. 2014
• The genome, proteome and phylogenetic analysis of Sinorhizobium meliloti phage ΦM12, the founder of a new group of T4-superfamily phages.  450:84-97. 2014
• The structure of Sinorhizobium meliloti phage ΦM12, which has a novel T=19l triangulation number and is the founder of a new group of T4-superfamily phages.  450:205-212. 2014
• Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.  458:22-32. 2014
• Differential segregation of nodaviral coat protein and RNA into progeny virions during mixed infection with FHV and NoV.  454:280-290. 2014
• Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein.  454:139-144. 2014
• Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.  458:190-208. 2014
• Protection of ferrets from pulmonary injury due to H1N1 2009 influenza virus infection: immunopathology tractable by sphingosine-1-phosphate 1 receptor agonist therapy.  452:152-157. 2014
• Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals.  439:81-88. 2013
• Dual-color HIV reporters trace a population of latently infected cells and enable their purification.  446:283-292. 2013
• Susceptibility and adaptation to human TRIM5α alleles at positive selected sites in HIV-1 capsid.  441:162-170. 2013
• Chemical cross-linking of HIV-1 Env for direct TLR7/8 ligand conjugation compromises recognition of conserved antigenic determinants.  446:56-65. 2013
• Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection.  435:92-101. 2013
• Heat shock protein 90AB1 and hyperthermia rescue infectivity of HIV with defective cores.  436:162-172. 2013
• Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus.  442:114-121. 2013
• Snapshots: Chromatin control of viral infection.  435:141-156. 2013
• The role of proteolytic processing and the stable signal peptide in expression of the old world arenavirus envelope glycoprotein ectodomain.  436:127-133. 2013
• Sexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells.  434:2-4. 2012
• CD8 T cell defect of TNF-α and IL-2 in DNAM-1 deficient mice delays clearance in vivo of a persistent virus infection..  429:163-170. 2012
• Comparison of the convergent receptor utilization of a retargeted feline leukemia virus envelope with a naturally-occurring porcine endogenous retrovirus a.  427:118-126. 2012
• Disulfide-bond formation by a single cysteine mutation in adenovirus protein vi impairs capsid release and membrane lysis.  428:41-47. 2012
• Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor pf-429242.  423:14-22. 2012
• In vitro evolution of h5n1 avian influenza virus toward human-type receptor specificity.  422:105-113. 2012
• Wild-type coxsackievirus infection dramatically alters the abundance, heterogeneity, and immunostimulatory capacity of conventional dendritic cells in vivo.  429:74-90. 2012
• Treatment of mice with human monoclonal antibody 24 h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection.  414:146-152. 2011
• Arenavirus reverse genetics: New approaches for the investigation of arenavirus biology and development of antiviral strategies.  411:416-425. 2011
• Decoding arenavirus pathogenesis: Essential roles for alpha-dystroglycan-virus interactions and the immune response.  411:170-179. 2011
• Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza h5n1 viruses.  413:139-147. 2011
• Extraneural manifestations of prion infection in gpi-anchorless transgenic mice.  411:1-8. 2011
• Molecular characterization of drosophila cells persistently infected with flock house virus.  419:43-53. 2011
• Receptor specificity of subtype h1 influenza a viruses isolated from swine and humans in the united states.  412:401-410. 2011
• The ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway.  419:72-83. 2011
• Antibody-mediated neutralization of ebola virus can occur by two distinct mechanisms.  401:228-235. 2010
• Crystallization and preliminary X-ray diffraction analysis of human adenovirus.  402:209-214. 2010
• Treatment with a sphingosine analog does not alter the outcome of a persistent virus infection.  397:260-269. 2010
• Insights into adenovirus host cell interactions from structural studies.  384:380-388. 2009
• Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection.  390:151-156. 2009
• Tomato bushy stunt virus (TBSV), a versatile platform for polyvalent display of antigenic epitopes and vaccine design.  388:185-190. 2009
• TOJ3, a v-jun target with intrinsic oncogenic potential, is directly regulated by Jun via a novel AP-1 binding motif.  378:371-376. 2008
• A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding.  382:107-114. 2008
• An aptamer that neutralizes r5 strains of hiv-1 binds to core residues of gp120 in the ccr5 binding site.  381:46-54. 2008
• Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis b surface antigen particles.  373:72-84. 2008
• Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics.  377:170-183. 2008
• Conservation of fiber structure and CD46 usage by subgroup B2 adenoviruses.  375:573-579. 2008
• Feline immunodeficiency virus orfa alters gene expression of splicing factors and proteasome-ubiquitination proteins.  371:394-404. 2008
• Functional hierarchy of two L domains in porcine endogenous retrovirus (PERV) that influence release and infectivity.  375:637-645. 2008
• Neutralizing activity of antibodies to the v3 loop region of hiv-1 gp120 relative to their epitope fine specificity.  381:251-260. 2008
• Relationship of hiv-1 and siv envelope glycoprotein trimer occupation and neutralization.  377:364-378. 2008
• A comparative immunogenicity study of hiv-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.  366:245-262. 2007
• Analysis of the neutralization breadth of the anti-v3 antibody f425-b4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis.  364:441-453. 2007
• Changes in the V3 region of gp 120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta 32 heterozygote.  362:163-178. 2007
• Chronic wasting disease of deer and elk in transgenic mice: Oral transmission and pathobiology.  365:136-143. 2007
• Deletions within the 5 ' utr of coxsackievirus b3: Consequences for virus translation and replication.  360:120-128. 2007
• Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse .  361:93-102. 2007
• Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease.  363:156-165. 2007
• Mapping and restriction of a dominant viral CD4(+) T cell core epitope by both MHC class I and MHC class II.  363:113-123. 2007
• Measles virus-dendritic cell interaction via slam inhibits innate immunity: Selective signaling through tlr4 but not other tlrs mediates suppression of il-12 synthesis.  358:251-257. 2007
• Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion.  360:264-274. 2007
• The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2.  367:367-374. 2007
• Vesicular stomatitis virus glycoprotein g activates a specific antiviral toll-like receptor 4-dependent pathway.  362:304-313. 2007
• Cd4 t cell control primary measles virus infection of the cns: Regulation is dependent on combined activity with either cd8 t cells or with b cells: Cd4, cd8 or b cells alone are ineffective.  347:234-245. 2006
• Characterization of polymorphism displayed by the coat protein mutants of tomato bushy stunt virus.  349:222-229. 2006
• Phosphoinositide 3-kinase: From viral oncoprotein to drug target.  344:131-138. 2006
• Rescue of the prototypic arenavirus LCMV entirely from plasmid.  350:370-380. 2006
• The infectivity and host range of the ecotropic porcine endogenous retrovirus, perv-c, is modulated by residues in the c-terminal region of its surface envelope protein.  346:108-117. 2006
• Viral persistence: Parameters, mechanisms and future predictions.  344:111-118. 2006
• An alternative conformation of the gp41 heptad repeat 1 region coiled coil exists in the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor.  338:133-143. 2005
• Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins.  331:33-46. 2005
• Characterization of antibody responses to purified hiv-1 gp120 glycoproteins fused with the molecular adjuvant c3d.  340:277-284. 2005
• Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen.  333:293-300. 2005
• Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding lassa virus nucleoprotein.  335:87-98. 2005
• Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion.  341:215-230. 2005
• In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity.  332:1-7. 2005
• Maturation of a tetravirus capsid alters the dynamic properties and creates a metastable complex.  334:17-27. 2005
• Selective recognition of oligomeric hiv-1 primary isolate envelope glycoprotelins by potently neutralizing ligands requires efficient precursor cleavage.  332:145-156. 2005
• Systemic trafficking of plant virus nanoparticles in mice via the oral route.  343:224-235. 2005
• Does toll-like receptor 3 play a biological role in virus infections?.  322:231-238. 2004
• Effect of polyanion-resistance on HIV-1 infection.  325:389-398. 2004
• Electron microscopy of an alpha-dystroglycan fragment containing receptor sites for lymphocytic choriomeningitis virus and laminin, and use of the receptoid body as a reagent to neutralize virus.  325:207-215. 2004
• Factors limiting the immunogenicity of hiv-1 gp120 envelope glycoproteins.  330:233-248. 2004
• Generation and analysis of an rna vaccine that protects against coxsackievirus b3 challenge.  330:196-208. 2004
• Measles virus interacts with human slam receptor on dendritic cells to cause immuno suppression.  323:292-302. 2004
• Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity.  329:454-464. 2004
• N-linked glycosylation in the CXCR4 N-tenninus inhibits binding to HIV-1 envelope glycoproteins.  324:140-150. 2004
• The refined structure of nudaurelia capensis omega virus reveals control elements for a t=4 capsid maturation.  318:192-203. 2004
• Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus.  325:432-445. 2004
• Alpha-dystroglycan can mediate arenavirus infection in the absence of beta-dystroglycan.  316:213-220. 2003
• Analysis of rna packaging in wild-type and mosaic protein capsids of flock house virus using recombinant baculovirus vectors.  305:10-24. 2003
• Effects of the cowpea chlorotic mottle bromovirus beta-hexamer structure on virion assembly.  306:280-288. 2003
• Evidence for assembly-dependent folding of protein and rna in an icosahedral virus.  314:26-33. 2003
• Human rhinovirus capsid dynamics is controlled by canyon flexibility.  314:34-44. 2003
• Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).  308:37-47. 2003
• Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions.  314:168-178. 2003
• Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.  315:159-173. 2003
• Structure-based, targeted deglycosylation of hiv-1 gp120 and effects on neutralization sensitivity and antibody recognition.  313:387-400. 2003
• Detection of antibodies against the four subtypes of ebola virus in sera from any species using a novel antibody-phage indicator assay.  300:236-243. 2002
• Inducible system in human hepatoma cell lines for hepatitis C virus production.  303:79-99. 2002
• One, two, or three step: Measles virus receptor dance.  299:162-163. 2002
• Stability of rice yellow mottle virus and cellular compartmentalization during the infection process in oryza sativa (l).  297:98-108. 2002
• A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37.  279:78-89. 2001
• Antibody neutralization epitopes and integrin binding sites on nonenveloped viruses.  288:189-191. 2001
• Antibody neutralization of the extracellular enveloped form of vaccinia virus.  280:132-142. 2001
• Characterization of virus-like particles assembled in a recombinant baculovirus system expressing the capsid protein of a fish nodavirus.  290:50-58. 2001
• Disruption of differentiated functions during viral infection in vivo - v. Mapping of a locus involved in susceptibility of mice to growth hormone deficiency due to persistent lymphocytic choriomeningitis virus infection.  281:61-66. 2001
• Evidence that the hypermutated m protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive cns disease.  291:215-225. 2001
• Specific packaging of nodaviral rna2 requires the n-terminus of the capsid protein.  285:165-175. 2001
• Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele.  270:98-110. 2000
• Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.  272:438-449. 2000
• Antibody and virus: Binding and neutralization.  270:1-3. 2000
• Cell receptors involved in adenovirus entry.  274:1-4. 2000
• Coxsackievirus infection of the pancreas: Evaluation of receptor expression, pathogenesis, and immunopathology.  271:276-288. 2000
• Cytokine-mediated control of viral infections.  273:221-227. 2000
• Defining parameters for successful immunocytotherapy of persistent viral infection.  266:257-263. 2000
• Enhancing DNA immunization.  268:233-238. 2000
• Human xenograft models for virus infection.  271:215-219. 2000
• Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.  274:391-401. 2000
• Synergistic interactions of antibodies in rate of virus neutralization.  270:386-396. 2000
• Transgenic mice expressing human hla and cd8 molecules generate hla-restricted measles virus cytotoxic t lymphocytes of the same specificity as humans with natural measles virus infection.  275:286-293. 2000
• V and c proteins of measles virus function as virulence factors in vivo.  267:80-89. 2000
• Vaccination to treat persistent viral infection.  268:411-419. 2000
• Conditional cell transformation by doxycycline-controlled expression of the MC29 v-myc allele.  253:193-207. 1999
• Augmentation of human influenza a virus-specific cytotoxic t lymphocyte memory by influenza vaccine and adjuvanted carriers (iscoms).  259:256-261. 1999
• Carboxy-terminal five amino acids of the nucleocapsid protein of vesicular stomatitis virus are required for encapsidation and replication of genome rna.  259:219-227. 1999
• High-yield reassortant influenza vaccine production virus has a mutation at an hla-a 2.1-restricted cd8(+) ctl epitope on the ns1 protein.  259:135-140. 1999
• Lymphotoxin-beta-deficient mice show defective antiviral immunity.  260:136-147. 1999
• Plasmid DNA vaccines are effective in the absence of ifn gamma.  263:175-183. 1999
• Rice tungro bacilliform virus open reading frame 3 encodes a single 37-kda coat protein.  253:319-326. 1999
• Structural and functional studies of the measles virus hemagglutinin: Identification of a novel site required for cd46 interaction.  256:142-151. 1999
• The refined crystal structure of cowpea mosaic virus at 2.8 Å resolution.  265:20-34. 1999
• Use of a high-affinity peptide that aborts mhc-restricted cytotoxic t lymphocyte activity against multiple viruses in vitro and virus-induced immunopathologic disease in vivo.  256:246-257. 1999
• Comparison of the native ccmv virion with in vitro assembled ccmw virions by cryoelectron microscopy and image reconstruction.  244:212-218. 1998
• Crystallization and preliminary x-ray analysis of the dsdna bacteriophage hk97 mature empty capsid.  243:113-118. 1998
• Effects of mutations in the c-terminal region of nia protease on cis-cleavage between nia and nib.  241:94-100. 1998
• Identification of d-b- and k-b-restricted subdominant cytotoxic t-cell responses in lymphocytic choriomeningitis virus-infected mice.  240:158-167. 1998
• Interactions among hiv gp120, cd4, and cxcr4: Dependence on cd4 expression level, gp120 viral origin, conservation of the gp120 cooh- and nh(2)-termini and v1/v2 and v3 loops, and sensitivity to neutralizing antibodies.  248:394-405. 1998
• Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (fab 19) define a unique epitope on the fusion (f) glycoprotein.  252:373-375. 1998
• The bis-azo compound FP-21399 inhibits HIV-1 replication by preventing viral entry.  244:530-541. 1998
• The df-1 chicken fibroblast cell line: Transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses.  248:295-304. 1998
• How viruses escape from cytotoxic t lymphocytes: Molecular parameters and players.  234:179-185. 1997
• Low-affinity cytotoxic t-lymphocytes require ifn-gamma to clear an acute viral infection.  229:349-359. 1997
• Measles virus recognizes its receptor, cd46, via two distinct binding domains within scr1-2.  233:174-184. 1997
• Revelations of a captive: Retroviral qin and the oncogenicity of winged helix proteins.  238:1-7. 1997
• The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft.  238:22-29. 1997
• The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic t cell epitope that is restricted by both h-2d(b) and h-2k(b) molecules.  234:62-73. 1997
• The structure of cucumber mosaic virus: Cryoelectron microscopy, x-ray crystallography, and sequence analysis.  232:91-97. 1997
• Viral persistent infection affects both transcriptional and posttranscriptional regulation of neuron-specific molecule GAP43.  230:147-154. 1997
• A neural substrate of hyperactivity in borna disease: Changes in brain dopamine receptors.  222:332-338. 1996
• Comparative properties of feline immunodeficiency virus (fiv) and human immunodeficiency virus type 1 (hiv-1) proteinases prepared by total chemical synthesis.  224:268-275. 1996
• Detection of borna disease virus antigen and rna in human autopsy brain samples from neuropsychiatric patients.  223:272-282. 1996
• Effects of internal cleavages and mutations in the C-terminal region of NIa protease of turnip mosaic potyvirus on the catalytic activity.  226:183-190. 1996
• Influence of orf2 on host cell tropism of feline immunodeficiency virus.  215:10-16. 1996
• Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against hsv.  215:101-106. 1996
• Suppression of lymphocytic choriomeningitis virus-induced growth hormone deficiency syndrome by disease-negative virus variants.  223:113-119. 1996
• Topically applied human recombinant monoclonal igg(1) antibody and its fab and f(ab')(2) fragments protect mice from vaginal transmission of hsv-2.  225:213-215. 1996
• Viral persistence in neurons alters synaptic plasticity and cognitive functions without destruction of brain cells.  220:508-515. 1996
• A quail long-term cell-culture transformed by a chimeric jun oncogene.  207:321-326. 1995
• An essential role for type-1 interferon-gamma in terminating persistent viral-infection.  212:244-250. 1995
• Assembly of the t=4 nudaurelia capensis omega virus capsid protein, posttranslational cleavage, and specific encapsidation of its messenger-rna in a baculovirus expression system.  207:89-97. 1995
• CTL escape viral variants. II. Biologic activity in vivo.  211:443-450. 1995
• Ctl escape viral variants .1. Generation and molecular characterization.  210:29-40. 1995
• Feline immunodeficiency virus (fiv)-specific cytotoxic t-lymphocytes from chronically infected cats are induced in-vitro by retroviral vector-transduced feline t-cells expressing the fiv capsid protein.  209:390-399. 1995
• Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines.  209:643-648. 1995
• The remarkable coding strategy of borna-disease virus - a new member of the nonsegmented negative strand rna viruses.  210:1-8. 1995
• A chromatographic analysis of capsid protein isolated from alfalfa mosaic-virus - zinc-binding and proteolysis cause distinct charge heterogeneity.  204:843-846. 1994
• Antigen presentation and cytotoxic t-lymphocyte killing studied in individual, living cells.  201:330-340. 1994
• Development of cowpea mosaic-virus as a high-yielding system for the presentation of foreign peptides.  202:949-955. 1994
• Direct imaging of interactions between an icosahedral virus and conjugate f-ab fragments by cryoelectron microscopy and x-ray crystallography.  204:777-788. 1994
• Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus.  205:546-553. 1994
• Mechanism of lymphocytic choriomeningitis virus entry into cells.  198:1-9. 1994
• Receptor specificity in human, avian, and equine h2 and h3 influenza-virus isolates.  205:17-23. 1994
• Crystallization and preliminary-x-ray characterization of tobacco streak virus and a proteolytically modified form of the capsid protein.  196:328-331. 1993
• Cytotoxic T-lymphocytes cleanse viral gene-products from individually infected neurons and lymphocytes in mice persistently infected with lymphocytic choriomeningitis virus.  197:463-467. 1993
• Expression of an animal virus antigenic site on the surface of a plant-virus particle.  197:366-374. 1993
• Molecular-cloning and characterization of deoxyuridine triphosphatase from feline immunodeficiency virus (fiv).  196:451-457. 1993
• Preliminary-x-ray data-analysis of crystalline cowpea chlorotic mottle virus.  193:234-241. 1993
• Virus-induced immunosuppression .1. Age at infection relates to a selective or generalized defect.  195:397-405. 1993
• Comoviruses and enteroviruses share a t-cell epitope.  186:238-246. 1992
• Measles-virus inhibits mitogen-induced t-cell proliferation but does not directly perturb the t-cell activation process inside the cell.  187:280-289. 1992
• Regulation of gene-expression directed by the long terminal repeat of the feline immunodeficiency virus.  187:165-177. 1992
• Sequence and analysis of the capsid protein of nudaurelia-capensis omega-virus, an insect virus with t=4 icosahedral symmetry.  190:806-814. 1992
• Wounding acts as a tumor promoter in chickens inoculated with avian-sarcoma virus-17.  188:373-377. 1992
• Avian cells expressing the murine Mx1 protein are resistant to influenza virus infection.  180:754-762. 1991
• The n2 neuraminidase of human influenza-virus has acquired a substrate-specificity complementary to the hemagglutinin receptor specificity.  180:10-15. 1991
• Molecular characterization of the Borna disease agent.  179:853-856. 1990
• Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope.  178:393-400. 1990
• A zinc-finger-type binding domain in tobacco streak virus coat protein.  168:48-56. 1989
• Lymphocytic choriomeningitis virus selectively alters differentiated but not housekeeping functions - block in expression of growth-hormone gene is at the level of transcriptional initiation.  168:232-235. 1989
• Retroviral-mediated transfer and expression of hepatitis B e antigen in human primary skin fibroblasts and Epstein-Barr virus-transformed B lymphocytes.  168:31-39. 1989
• The primary structure of the lymphocytic choriomeningitis virus l-gene encodes a putative rna-polymerase.  169:377-384. 1989
• Analyses of the cyto-toxic lymphocyte-t responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus.  162:321-327. 1988
• Hiv and hcmv coinfect brain-cells in patients with aids.  165:286-290. 1988
• The histidine-221 to tyrosine substitution in v-mos abolishes its biological function and its protein-kinase activity.  164:114-120. 1988
• Virus lymphocyte interactions .3. Biologic parameters of a virus variant that fails to generate ctl and establishes persistent infection in immunocompetent hosts.  164:507-516. 1988
• Virus lymphocyte interactions .4. Molecular characterization of lcmv armstrong (ctl+) small genomic segment and that of its variant, clone-13 (ctl-).  164:517-522. 1988
• Molecular characterization of the genomic-s rna segment from lymphocytic choriomeningitis virus.  157:145-155. 1987
• Perturbation of differentiated functions in vivo during persistent viral infection. III. Decreased growth hormone mRNA.  156:214-220. 1987
• Recognition of mono-valent sialosides by influenza-virus h-3 hemagglutinin.  160:502-506. 1987
• Nucleotide sequence of the CMII v-myc allele.  154:219-223. 1986
• Antibodies against small nuclear ribonucleoproteins immunoprecipitate complexes containing ts110 Moloney murine sarcoma virus genomic and messenger RNAs.  152:87-99. 1986
• Cytoskeletal organization, vinculin-phosphorylation, and fibronectin expression in transformed fibroblasts with different cell morphologies.  151:50-65. 1986
• Moloney murine sarcoma-virus encoded p37mos expressed in yeast has protein-kinase activity.  152:502-506. 1986
• Molecular and biological properties of MH2D12, a spontaneous mil deletion mutant of avian oncovirus MH2.  142:248-262. 1985
• Nucleotide sequence analysis of the chicken gene c-mil, the progenitor of the retroviral oncogene v-mil.  143:359-367. 1985
• An endogenous virus from lophortyx quail is the prototype for envelope subgroup-i of avian retroviruses.  143:595-602. 1985
• Avian retrovirus s13 - properties of the genome and of the transformation-specific protein.  145:154-164. 1985
• Cloned DNA of defective avian-sarcoma virus mutant la46 encodes the cis-acting temperature-sensitive defect in replication.  143:684-689. 1985
• Establishment of cell-lines persistently infected with foot-and-mouth-disease virus.  145:24-35. 1985
• H-1, c-13, and p-31 nuclear magnetic-resonance studies of cowpea mosaic-virus - detection and exchange of polyamines and dynamics of the rna.  141:43-50. 1985
• Influenza-virus hemagglutinins differentiate between receptor determinants bearing n-acetylneuraminic, n-glycollylneuraminic, and n,o-diacetylneuraminic acids.  144:279-282. 1985
• Isolation of 3 new avian-sarcoma viruses - asv-9, asv-17, and asv-25.  143:680-683. 1985
• Leukemogenicity of avian oncovirus-s13.  147:466-469. 1985
• Molecular-cloning of the prcii sarcoma viral genome and the chicken proto-oncogene c-fps.  143:300-308. 1985
• Perturbation of differentiated functions during viral infection in vivo. I. Relationship of lymphocytic choriomeningitis virus and host strains to growth hormone deficiency.  142:158-174. 1985
• Perturbation of differentiated functions during viral infection in vivo. II. Viral reassortants map growth hormone defect to the S RNA of the lymphocytic choriomeningitis virus genome.  142:175-182. 1985
• S13, a rapidly oncogenic replication-defective avian retrovirus.  145:141-153. 1985
• Immunological analysis of v-myc gene products using antibodies against a myc-specific synthetic peptide.  136:348-358. 1984
• Structural relationship between the chicken protooncogene c-mil and the retroviral oncogene v-mil.  137:217-224. 1984
• Antigenic analyses of influenza-virus hemagglutinins with different receptor-binding specificities.  138:174-177. 1984
• Black beetle virus - crystallization and particle symmetry.  133:119-127. 1984
• Early events in the infection of human lymphocyte-b by epstein-barr virus - the internalization process.  132:186-198. 1984
• Differential sensitivity of human, avian, and equine influenza-a viruses to a glycoprotein inhibitor of infection - selection of receptor specific variants.  131:394-408. 1983
• Mapping of the major histocompatibility complex and viral-antigens on the plasma-membrane of a measles virus-infected cell.  127:426-437. 1983
• Pathogenesis of the slow disease of the central nervous-system associated with wild mouse virus .3. Role of input virus and mcf recombinants in disease.  128:154-165. 1983
• Receptor determinants of human and animal influenza-virus isolates - differences in receptor specificity of the hemagglutinin-h-3 based on species of origin.  127:361-373. 1983
• Sialyloligosaccharide receptors of binding variants of polyoma-virus.  130:281-289. 1983
• The spherically averaged structures of cowpea mosaic-virus components by x-ray solution scattering.  127:65-73. 1983
• Ts transformation mutants of avian-sarcoma virus-prcii - lack of strict correlation between transforming ability and properties of the p105-associated kinase.  125:219-229. 1983
• A temperature-sensitive lesion affecting levels of transformation-specific viral RNA in a mutant of avian sarcoma virus PRCII.  116:646-649. 1982
• Class-ii defective avian-sarcoma viruses - comparative-analysis of genome structure.  120:453-464. 1982
• DNA and histone synthesis in butyrate-inhibited BSC-1 cells infected with SV40.  116:196-206. 1982
• Genome structure of the defective avian-sarcoma virus prciv.  117:156-164. 1982
• Structural similarities of proteins encoded by 3 classes of avian-sarcoma viruses.  121:274-287. 1982
• Structural-analysis of rauscher virus gp70 using monoclonal-antibodies - sites of antigenicity and p15(e) linkage.  123:187-205. 1982
• Avian-sarcoma virus prcii - conditional mutants temperature sensitive in the maintenance of fibroblast transformation.  109:193-197. 1981
• Characteristics of avian-sarcoma virus-strain prciv and comparison with strain prcii-p.  114:451-462. 1981
• Characterization of a 105,000 molecular-weight gag-related phosphoprotein from cells transformed by the defective avian-sarcoma virus prcii.  108:98-110. 1981
• Characterization of the transformation-specific sequences of avian erythroblastosis virus in normal vertebrate cells.  111:418-426. 1981
• Endogenous proviruses of random-bred chickens and ring-necked pheasants - analysis with restriction endonucleases.  108:222-229. 1981
• Esh avian-sarcoma virus codes for a gag-linked transformation-specific protein with an associated protein-kinase activity.  111:386-400. 1981
• Integration of avian-sarcoma virus-DNA in chicken-cells.  108:208-221. 1981
• Monoclonal-antibodies to lymphocytic choriomeningitis and pichinde viruses - generation, characterization, and cross-reactivity with other arenaviruses.  113:73-85. 1981
• Polyoma-virus recognizes specific sialyloligosaccharide receptors on host-cells.  109:188-192. 1981
• The 28 S genomic RNA of avian sarcoma virus PRCII codes for the transformation-specific polyprotein P105.  112:757-761. 1981
• The pathogenicity and defectiveness of prcii - a new type of avian-sarcoma virus.  108:1-12. 1981
• The transformation-specific proteins of avian (fujinami and prc-ii) and feline (snyder-theilen and gardner-arnstein) sarcoma-viruses are immunologically related.  110:411-419. 1981
• Tyrosine-specific protein-kinase activity associated with p105 of avian-sarcoma virus prcii.  109:223-228. 1981
• Attenuation of avian reticuloendotheliosis virus - loss of the defective transforming component during serial passage of oncogenic virus in fibroblasts.  101:304-306. 1980
• Cell-free translation of avian erythroblastosis virus RNA yields two specific and distinct proteins with molecular weights of 75,000 and 40,000.  100:475-483. 1980
• Crystalline cowpea mosaic-virus.  101:319-324. 1980
• Pathogenesis of the slow disease of the central nervous-system associated with wild mouse virus .2. Role of virus and host gene-products.  107:180-193. 1980
• Polyoma-virus adsorbs to specific sialyloligosaccharide receptors on erythrocytes.  103:505-509. 1980
• Recovered src genes are polymorphic and contain host markers.  105:71-85. 1980
• The genomic RNA of avian reticuloendotheliosis virus REV.  100:450-461. 1980
• Avian acute leukemia virus MC29: conserved and variable RNA sequences and recombination with helper virus.  99:121-134. 1979
• Avian erythroblastosis virus - transformation-specific sequences form a contiguous segment of 3.25-kb located in the middle of the 6-kb genome.  97:366-377. 1979
• Avian oncovirus mh2 is defective in gag, pol, and env.  92:278-284. 1979
• Avian oncovirus-mh2 - preferential growth in macrophages and exact size of the genome.  96:302-306. 1979
• Nonconditional replication-defective mutant of the schmidt-ruppin strain of rous-sarcoma virus.  92:285-290. 1979
• Protein-structure of lymphocytic choriomeningitis virus - evidence for a cell-associated precursor of the virion glycopeptides.  99:111-120. 1979
• Restitution of fibroblast-transforming ability in src deletion mutants of avian-sarcoma virus during animal passage.  93:413-426. 1979
• B-mux - unique murine c-type virus containing env gene of xenotropic viruses and gag gene of ecotropic virus.  90:255-264. 1978
• Biological, immunological, and biochemical evidence that hix virus is a recombinant between moloney leukemia-virus and a murine xenotropic c-type virus.  90:241-254. 1978
• Concordance of rna termini of recombinants from crosses between avian retroviruses with different termini.  85:367-377. 1978
• Defectiveness of mill hill 2, a carcinoma-inducing avian oncovirus.  89:162-178. 1978
• Genetic-analysis of defectiveness in strain mc29 avian-leukosis virus.  88:213-221. 1978
• Influence of carbohydrate on antigenicity of envelope glycoprotein of avian-myeloblastosis virus and b77 avian-sarcoma virus.  86:193-204. 1978
• Protein-structure of lymphocytic choriomeningitis virus - identification of virus structural and cell associated polypeptides.  89:133-145. 1978
• Structural-analysis of major envelope glycoprotein (gp70) of amphotropic and ecotropic type-c viruses of wild mice.  84:348-358. 1978
• Structure of southern bean mosaic-virus at 5 a resolution.  85:187-197. 1978
• Ts-pol mutants of avian-sarcoma viruses - mapping and demonstration of single cycle recombinants.  87:21-33. 1978
• Biological and biochemical studies on inactivation of avian onco-viruses by uv irradiation.  77:689-704. 1977
• Defectiveness of avian myelocytomatosis virus mc29 - isolation of long-term nonproducer cultures and analysis of virus-specific polypeptide-synthesis.  82:431-448. 1977
• Endogenous leukosis viruses in avian family phasianidae.  76:740-750. 1977
• Glycolipids of chick-embryo fibroblasts infected with temperature-sensitive mutants of avian-sarcoma viruses.  76:485-493. 1977
• Phenotypic mixing between reticuloendotheliosis virus and avian-sarcoma viruses.  80:127-135. 1977
• Terminal oligonucleotides of avian tumor-virus rnas are genetically linked.  82:472-492. 1977
• Antibody-complement interactions with purified lymphocytic choriomeningitis virus.  73:59-71. 1976
• Avian-sarcoma virus mutant that is temperature sensitive for virion assembly.  69:35-49. 1976
• Inactivation and lysis of oncornaviruses by human-serum.  74:432-440. 1976
• Inhibition of avian-sarcoma virus-replication by glucosamine - specific effect on synthesis and processing of viral-proteins.  71:402-411. 1976
• Structure of southern bean mosaic-virus at 22.5-a resolution.  75:394-400. 1976
• Subgroup-specific antigenic determinants of avian RNA tumor virls structural proteins: analysis of virus recombinants.  73:372-380. 1976
• Temperature-sensitive mutants of avian-sarcoma viruses - genetic recombination with wild-type sarcoma-virus and physiological analysis of multiple mutants.  69:23-34. 1976
• Temperature-sensitive mutants of avian-sarcoma viruses - genetic-recombination between multiple or coordinate mutants and avian-leukosis viruses.  75:48-59. 1976
• RNA tumor virus specific sequences in nuclear DNA of several avian species.  65:524-534. 1975
• Susceptibility and resistance of chicken macrophages to avian RNA tumor viruses.  67:553-565. 1975
• Determination of defective function in 2 mutants of rous-sarcoma virus.  61:559-574. 1974
• Inhibition of avian-sarcoma virus replication by glucosamine.  58:449-456. 1974
• RNA tumor viruses of pheasants: characterization of avian leukosis subgroups F and G.  60:558-571. 1974
• Formation of syncytia in human lymphoblastoid cells infected with type c viruses.  55:453-463. 1973
• Genetic recombinants and heterozygotes derived from endogenous and exogenous avian RNA tumor viruses.  52:535-552. 1973
• Properties of an oncornavirus glycoprotein: Evidence for its presence on the surface of virions and infected cells.  55:464-475. 1973
• RNA species obtained from clonal lines of avian sarcoma and from avian leukosis virus.  54:207-219. 1973
• Isolation and characterization of ribonucleoprotein substructures from Rous sarcoma virus.  50:65-75. 1972
• Lipid studies of Rous sarcoma virus and host cell membranes.  50:550-557. 1972
• An avian leukosis virus related to rsv(o): Properties and evidence for helper activity.  43:223-234. 1971
• Conditional lethal mutants of avian sarcoma viruses. I. Physiology of ts 75 and ts 149.  43:375-389. 1971
• Conditional lethal mutants of avian sarcoma viruses. Ii. Analysis of the temperature-sensitive lesion in ts 75.  46:745-753. 1971
• Genetically stable reassortment of markers during mixed infection with avian tumor viruses.  46:947-952. 1971
• Induction of avian tumor viruses in normal cells by physical and chemical carcinogens.  46:920-938. 1971
• Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses.  46:106-116. 1971
• Spontaneous segregation of nontransforming viruses from cloned sarcoma viruses.  46:939-946. 1971
• Transformation by rous sarcoma virus: Effects on cellular glycolipids.  44:609-621. 1971
• Glycoprotein components of avian and murine RNA tumor viruses.  41:631-646. 1970
• The reproductive and cell-transforming capacities of avian sarcoma virus b77: Inactivation with uv light.  42:163-170. 1970
• Tissue injury in lymphocytic choriomeningitis viral infection: Virus-induced immunologically specific release of a cytotoxic factor from immune lymphoid cells.  42:805-813. 1970
• Characteristics of two new avian tumor virus subgroups.  39:18-30. 1969
• Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions.  38:414-426. 1969
• Temperature sensitive mutants of an avian sarcoma virus.  39:930-931. 1969
• Effects of genetic cellular resistance on cell transformation and virus replication in chicken hematopoietic cell cultures infected with avian myeloblastosis virus (bai-a).  35:487-497. 1968
• Deae-dextran: Enhancement of cellular transformation induced by avian sarcoma viruses.  33:175-177. 1967
• Phenotypic mixing in the avian tumor virus group.  32:708-717. 1967
• Immunological relationships among envelope antigens of avian tumor viruses.  30:375-387. 1966
• Localization of avian tumor virus group-specific antigen in cell and virus.  29:377-384. 1966
• Patterns of viral interference in the avian leukosis and sarcoma complex.  30:368-374. 1966
• A heterogeneity of Rous sarcoma virus revealed by selectively resistant chick embryo cells.  25:237-247. 1965
• Presence of avian tumor virus group-specific antigen in nonproducing Rous sarcoma cells of the chicken.  27:233-236. 1965
• Reciprocal patterns of genetic resistance to avian tumor viruses in two lines of chickens.  26:664-672. 1965
• Observations on the surface of cells infected with Rous sarcoma virus.  20:75-87. 1963
• Studies on the assay and multiplication of avian myeloblastosis virus.  19:92-104. 1963
• An avian leukosis virus associated with stocks of Rous sarcoma virus.  17:184-194. 1962
• Localization of infectious virus and viral antigen in chick fibroblasts during successive stages of infection with Rous sarcoma virus.  13:528-544. 1961

Identity

International Standard Serial Number (ISSN)

• 0042-6822

Electronic International Standard Serial Number (EISSN)

• 1096-0341